rs151057624

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2

The NM_052813.5(CARD9):​c.1596C>T​(p.Asp532Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000318 in 1,560,296 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0017 ( 2 hom., cov: 34)
Exomes 𝑓: 0.00017 ( 3 hom. )

Consequence

CARD9
NM_052813.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 2.52

Publications

1 publications found
Variant links:
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]
CARD9 Gene-Disease associations (from GenCC):
  • deep dermatophytosis
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • predisposition to invasive fungal disease due to CARD9 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 9-136364317-G-A is Benign according to our data. Variant chr9-136364317-G-A is described in ClinVar as [Benign]. Clinvar id is 467796.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.52 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00171 (260/152324) while in subpopulation AFR AF = 0.00599 (249/41580). AF 95% confidence interval is 0.00538. There are 2 homozygotes in GnomAd4. There are 111 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD9NM_052813.5 linkc.1596C>T p.Asp532Asp synonymous_variant Exon 13 of 13 ENST00000371732.10 NP_434700.2 Q9H257-1A0A024R8F1
CARD9NM_052814.4 linkc.1442-155C>T intron_variant Intron 12 of 12 NP_434701.1 Q9H257-2
LOC124902309XR_007061863.1 linkn.84+865G>A intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD9ENST00000371732.10 linkc.1596C>T p.Asp532Asp synonymous_variant Exon 13 of 13 1 NM_052813.5 ENSP00000360797.5 Q9H257-1
ENSG00000289701ENST00000696169.1 linkn.*1224C>T non_coding_transcript_exon_variant Exon 12 of 13 ENSP00000512460.1
ENSG00000289701ENST00000696169.1 linkn.*1224C>T 3_prime_UTR_variant Exon 12 of 13 ENSP00000512460.1

Frequencies

GnomAD3 genomes
AF:
0.00170
AC:
259
AN:
152206
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00598
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000719
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000529
AC:
89
AN:
168280
AF XY:
0.000402
show subpopulations
Gnomad AFR exome
AF:
0.00791
Gnomad AMR exome
AF:
0.000346
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000431
GnomAD4 exome
AF:
0.000168
AC:
236
AN:
1407972
Hom.:
3
Cov.:
32
AF XY:
0.000155
AC XY:
108
AN XY:
695684
show subpopulations
African (AFR)
AF:
0.00603
AC:
194
AN:
32148
American (AMR)
AF:
0.000434
AC:
16
AN:
36904
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25270
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36872
South Asian (SAS)
AF:
0.0000125
AC:
1
AN:
80116
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47724
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
9.22e-7
AC:
1
AN:
1084856
Other (OTH)
AF:
0.000411
AC:
24
AN:
58386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00171
AC:
260
AN:
152324
Hom.:
2
Cov.:
34
AF XY:
0.00149
AC XY:
111
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00599
AC:
249
AN:
41580
American (AMR)
AF:
0.000718
AC:
11
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000773
Hom.:
0
Bravo
AF:
0.00193

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

CARD9-related disorder Benign:1
Sep 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Predisposition to invasive fungal disease due to CARD9 deficiency Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
13
DANN
Benign
0.90
PhyloP100
2.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151057624; hg19: chr9-139258769; API